Insider Trading April 21, 2026 04:59 PM

Dolphin Entertainment Director Receives 6,623 RSUs, Company Posts Revenue Gain in 2025

Director Michael Espensen adds restricted stock units as Dolphin reports higher revenue and smaller net loss for 2025

By Sofia Navarro DLPN
Dolphin Entertainment Director Receives 6,623 RSUs, Company Posts Revenue Gain in 2025
DLPN

Michael Espensen, a director at Dolphin Entertainment, acquired 6,623 restricted stock units on March 30, 2026, according to an SEC filing. The awards were granted at no cost and will vest in four equal installments between May 15, 2026 and March 31, 2027. Dolphin reported a 10% year-over-year revenue increase to $56.7 million for the fourth quarter and full year 2025 and recorded a notable reduction in net loss. The stock traded at $1.47 and has risen 50% over the past year, while InvestingPro analysis lists DLPN among undervalued opportunities and offers additional tips for investors.

Key Points

  • Director Michael Espensen was granted 6,623 RSUs on March 30, 2026; awards were granted at $0.00 per share and carry a total recorded value of $0.
  • The RSUs vest in four ratable installments on May 15, 2026; August 15, 2026; November 16, 2026; and March 31, 2027. After the award, Espensen directly holds 6,651 shares.
  • Dolphin reported a 10% year-over-year revenue increase to $56.7 million for the fourth quarter and full year 2025 and registered a notable reduction in net loss; the stock traded at $1.47 and has gained 50% over the past year.

Michael Espensen, who serves on the board of Dolphin Entertainment, Inc. (NASDAQ:DLPN), was awarded 6,623 restricted stock units (RSUs) on March 30, 2026, according to a recent filing with the U.S. Securities and Exchange Commission. The grant was recorded at a per-share price of $0.00, yielding a total recorded transaction value of $0.

The RSUs are set to vest on a ratable basis across four dates. The scheduled vesting dates are:

  • May 15, 2026
  • August 15, 2026
  • November 16, 2026
  • March 31, 2027

The SEC filing indicates that, following this award, Espensen directly holds 6,651 shares of Dolphin Entertainment common stock.

At the time the filing was noted, Dolphin's shares were trading at $1.47. That price point reflects a 50% increase over the prior 12 months despite periods of volatility. An InvestingPro analysis referenced in the filing describes the stock as appearing undervalued at current levels and places it among a list of the most undervalued stocks. The analysis also points to five additional InvestingPro Tips available to investors seeking deeper insight into DLPN's financial condition and prospects.


Separately, Dolphin Entertainment disclosed financial results for the fourth quarter and full year of 2025. The company reported a 10% year-over-year rise in revenue, which reached $56.7 million. The release also noted a notable reduction in net loss, an outcome the company characterized as an improvement in profitability metrics.

Market participants responded with measured caution following the results, as evidenced by stable premarket trading in the company's shares. The company framed the results as part of continued efforts to strengthen financial performance.

Observers assessing Dolphin's recent disclosures may weigh the combination of revenue growth and a smaller net loss when judging the company's financial health. The company’s ability to reduce net losses while increasing revenue could be seen as a positive indicator by some analysts. These financial developments were presented as part of the firm's recent operating and reporting activity.

Risks

  • Market reaction to reported results was cautious, reflected in stable premarket trading, which may indicate continued sensitivity in the equities market for entertainment companies - impacts investors and equity markets.
  • Vesting schedule means the awarded RSUs are not immediately liquid, creating timing and execution risk around future stock movements - impacts insider ownership dynamics and investor perception.
  • Despite revenue growth and reduced net loss, the company remains in a position where profitability metrics are improving but not necessarily fully stabilized, introducing financial performance uncertainty - impacts credit and equity assessments.

More from Insider Trading

OrbiMed Expands Stake in Traws Pharma via Strategic Private Placement Apr 28, 2026 Rexford Industrial Realty General Counsel Completes $1.18 Million Stock Sale Apr 28, 2026 Bicara Therapeutics CMO Executes Rule 10b5-1 Trading Plan Involving Share Sales and Option Exercises Apr 28, 2026 Abbott Laboratories Director Daniel Starks Executes Substantial Open Market Share Purchase Apr 28, 2026 BlackRock President Robert Kapito Executes $9.2 Million Share Sale Apr 28, 2026